Loading...
Loading...
VRAX| Name | Value |
|---|---|
| Revenues | 31.0K |
| Cost of Revenue | 33.3K |
| Gross Profit | -2.4K |
| Operating Expense | 173.1K |
| Operating I/L | -161.1K |
| Other Income/Expense | -7.1K |
| Interest Income | 0.0K |
| Pretax | -168.2K |
| Income Tax Expense | -5.5K |
| Net Income/Loss | -162.7K |
Virax Biolabs Group Limited is a biotechnology company specializing in the sale, distribution, and marketing of diagnostics test kits, med-tech, and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company offers a range of rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name, as well as med-tech and PPE products including infrared thermometers, pulse oximeters, masks, gloves, and employee protection equipment products under the ViraxCare brand name. It also distributes nebulizing machines and smart wearable devices for social distance guidelines compliance.
